← Back to Search

Implant

SI Joint Stabilization for Sacroiliac Joint Dysfunction (SILVIA Trial)

N/A
Waitlist Available
Research Sponsored by SI-BONE, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 21-75 at time of screening
Patient scheduled for multilevel (>3 levels) spinal fusion surgery with planned fixation to the pelvis using S2AI screws
Must not have
Any known sacral or iliac pathology
Prior pelvic fixation (i.e., patient already has S2AI or iliac bolts in place, current surgery indicated to revise this hardware)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing whether adding iFuse 3-D implants to a common back surgery can help reduce pain and prevent complications. It targets patients undergoing complex back surgery and aims to see if the implants provide extra support.

Who is the study for?
This trial is for adults aged 21-75 who are scheduled for multilevel spinal fusion surgery and can follow the study plan. They must not have severe osteoporosis, prior sacroiliac joint surgeries, or be pregnant. Those with drug abuse issues, uncontrolled psychiatric diseases, or involved in litigation related to SI joint/back pain cannot join.
What is being tested?
The study compares spine surgery outcomes with and without iFuse 3-D implants in patients needing long fusions to the pelvis. It aims to see if adding these implants improves stabilization of the sacroiliac joint during recovery.
What are the potential side effects?
Potential side effects may include typical surgical risks like infection, reaction to materials (titanium), nerve damage, blood clots, pain at implant site, and complications from anesthesia.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 21 and 75 years old.
Select...
I am scheduled for a major spine surgery involving more than 3 levels and fixation to the pelvis.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have a known condition affecting my sacrum or iliac bones.
Select...
I have had surgery to fix my pelvis before and need another one to adjust the hardware.
Select...
I am recommended to have surgery to fuse multiple levels of my spine.
Select...
I have a severe spinal condition where one of my vertebrae has slipped over another.
Select...
I have had surgery to fuse my sacroiliac joint.
Select...
My body is not suitable for the iFuse Implant treatment.
Select...
I have a diagnosed bone metabolism disorder.
Select...
I have an infection that could make surgery risky.
Select...
I have a neurological condition that could affect my ability to do physical therapy after surgery.
Select...
I have severe hip pain that might affect my recovery from complex spine surgery.
Select...
My surgeon plans to use an iliac screw for my pelvic surgery.
Select...
I have severe osteoporosis.
Select...
I have been diagnosed with fibromyalgia.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change from baseline in self-reported SI joint pain at 2 years
Incidence of SI Joint pain
Proportion with S2AI screw abnormality on CT scan
Secondary study objectives
Ambulatory and Work Status
Change from baseline pelvic incidence at 2 years
Change from baseline pelvic tilt at 2 years
+12 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Standard Care + iFuse 3-DExperimental Treatment2 Interventions
Multilevel Lumbar Fusion Surgery with additional placement of iFuse 3-D in a trajectory parallel to the S2AI screws
Group II: Standard careActive Control1 Intervention
Multilevel Lumbar Fusion Surgery

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The most common treatments for Sacroiliac Joint (SIJ) Dysfunction include structural interventions like the iFuse 3-D implants, which provide stability and support by fusing the joint, thereby reducing abnormal motion and alleviating pain. Manual therapy and specific exercises aim to improve joint function and muscle strength, enhancing stability and reducing discomfort. Injections, such as periarticular steroid injections, target inflammation and pain directly within the joint. These treatments are crucial for SIJ dysfunction patients as they address both the mechanical instability and the inflammatory components of the condition, leading to improved pain management and quality of life.
The Efficiency of Manual Therapy and Sacroiliac and Lumbar Exercises in Patients with Sacroiliac Joint Dysfunction Syndrome.Determination of the Prevalence From Clinical Diagnosis of Sacroiliac Joint Dysfunction in Patients With Lumbar Disc Hernia and an Evaluation of the Effect of This Combination on Pain and Quality of Life.Two-Year Outcomes from a Randomized Controlled Trial of Minimally Invasive Sacroiliac Joint Fusion vs. Non-Surgical Management for Sacroiliac Joint Dysfunction.

Find a Location

Who is running the clinical trial?

SI-BONE, Inc.Lead Sponsor
13 Previous Clinical Trials
2,586 Total Patients Enrolled
1 Trials studying Sacroiliac Joint Dysfunction
110 Patients Enrolled for Sacroiliac Joint Dysfunction
Daniel Cher, MDStudy DirectorSI-BONE
1 Previous Clinical Trials
103 Total Patients Enrolled

Media Library

iFuse 3-D in Bedrock Configuration (Implant) Clinical Trial Eligibility Overview. Trial Name: NCT04062630 — N/A
Sacroiliac Joint Dysfunction Research Study Groups: Standard care, Standard Care + iFuse 3-D
Sacroiliac Joint Dysfunction Clinical Trial 2023: iFuse 3-D in Bedrock Configuration Highlights & Side Effects. Trial Name: NCT04062630 — N/A
iFuse 3-D in Bedrock Configuration (Implant) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04062630 — N/A
Sacroiliac Joint Dysfunction Patient Testimony for trial: Trial Name: NCT04062630 — N/A
~38 spots leftby Dec 2025